You are on page 1of 5

See discussions, stats, and author profiles for this publication at: https://www.researchgate.

net/publication/237600216

Resin Screening to Optimize Chromatographic Separations

Article  in  Lc Gc North America · June 2001

CITATIONS READS
13 823

1 author:

Anurag Rathore
Indian Institute of Technology Delhi
326 PUBLICATIONS   4,345 CITATIONS   

SEE PROFILE

Some of the authors of this publication are also working on these related projects:

Development of a low-cost, high-throughput native polyacrylamide gel electrophoresis (N-PAGE) protocol for lipoprotein sub-fractionation using Quality by
Design approach View project

Supramolecular Chemistry View project

All content following this page was uploaded by Anurag Rathore on 14 March 2014.

The user has requested enhancement of the downloaded file.


616 LCGC VOLUME 19 NUMBER 6 JUNE 2001 www.chromatographyonline.com

Resin Screening to Optimize


Chromatographic Separations

The author presents an approach to screen resins for chromatographic


optimization in the purification process of a protein drug substance.
The protocol uses three steps to facilitate a rapid and efficient comparison
of different resins. In the first step, studies examine the binding between
the resin and the target molecule. Next, an identical shallow salt gradient
is used with all resins to generate information about the selectivity and
interactions between the product and the resin. The third step takes data
from preceding steps to provide a fair comparison of the various resins’
performance. The author used this approach with an anion-exchange
chromatography column in a typical protein purification process and was
able to identify an optimal resin.

Q uality and safety guidelines for


biotechnology products have
grown increasingly stringent
and have made chromatogra-
phy one of the most important and com-
processes. In the absence of a systematic
approach, investigators may end up with a
suboptimal resin or spend significant effort
to arrive at a decision.
Alternatively, they might screen chro-
monly used operations in downstream matographic media under a chosen set
processing. Although any number of chro- of operating conditions. Although this
matography resins can be suitable for a par- method allows for rapid screening, it suffers
ticular separation, physicochemical differ- from a major drawback: because the interac-
ences between the resins can significantly tions of a stationary phase with the various
affect their performance for a given problem. sample components are very specific, the
Resin selection is an integral part of chro- optimal elution conditions for different
matographic optimization in a purification resins fall in a broad range. Thus, if separa-
process, and it significantly affects the yield tions are performed using different resins
and purity of unit operation (1–6). Further- under identical operating conditions, the
more, resin cost generally is one of the resulting variations in elution profiles can
largest contributors to purification costs make it difficult to compare resin perfor-
(7,8). Few articles in the literature, however, mances. Figure 1 shows the change in selec-
address the issue of efficient chromatogra- tivity during a gradient elution separation
phy resin screening (5,6,9). after changing the slope of the gradient. An
Screening chromatographic media is com- identical ion-exchange chromatography gra-
plicated by the numerous products available dient for salt starting with a concentration of
as well as the large number of variables that 0 and going to 2 is performed with
users must consider. Comparison based on columns packed with resins A and B. Resin
full optimization of all conditions for each A appears to provide a better separation;
Anurag S. Rathore resin is resource-intensive and impractical in however, as Figure 1 shows, resin B would
Bioprocess and Formulation industrial environments. For this reason, yield better resolution if the gradient slope
Technology, Pharmacia Corp., investigators typically will work with a lim- were halved.
Mail Stop GG3K, ited number of resins such as those with The approach described in the following
700 Chesterfield Parkway North, which they are familiar or those that are rec- sections bridges the gap between the two
Chesterfield, Missouri 63198, ommended in the literature. Analysts will extremes mentioned above and provides a
e-mail Anurag.S.Rathore@ select the first resin that delivers satisfactory rapid and fair comparison of chromato-
pharmacia.com performance and incorporate it into their graphic media from different vendors for a
618 LCGC VOLUME 19 NUMBER 6 JUNE 2001 www.chromatographyonline.com

Resin A Resin B Resin B Mode of chromatography

Prepare list of 5–10 resin candidates


based on experience, literature
precedents, and vendor input

Perform resin screening

0 x 2x 0 x 2x 0 x/2 x
Salt concentration Optimize operating conditions

Figure 1: Effect of gradient slope on selectivity. Figure 2: Optimization of a chromato-


graphic separation.

given separation problem. The primary too strongly (indicated by the absence of test gradient of salt concentration (cA to c B)
objective of my study is to select a resin that product either in the flowthrough or the elu- in D column volumes. I choose a broad,
yields the best selectivity for a particular sep- ent), the resin should be rejected from fur- shallow gradient to ensure product elution
aration. In practice, other issues such as the ther consideration. with all resins and magnify selectivity differ-
physical and chemical stability of the pack- In the next step, I pack columns separately ences. I keep other operating parameters —
ing and resin lifetime should be considered with resins that are still under consideration such as column dimensions, column vol-
as well. and perform separations using an identical ume, buffer, protein loading, and linear

Procedure
Optimization of chromatographic separa-
tion: Figure 2 illustrates my strategy for opti-
mizing a chromatographic separation. After Pick pH and buffer
selecting the mode of chromatography, I
prepare a list of 5–10 resin candidates based Pick a Step 1: Batch experiment
upon past experience with the molecule, lit- resin for checking binding
erature precedents, and input from chro-
matography media vendors. I screen the
identified resins using the protocol defined Is binding
appropriate? No
in the next section. Finally, I optimize the
operating parameters — buffer conditions End
Yes
and protein loading — for each chromatog- Remove resin
raphy step. Step 2: Run a test gradient
from further
Resin screening protocol: Figure 3 illus- consideration
trates the three-step resin screening strategy.
Although the procedure was designed for Is selectivity No
ion-exchange chromatography, it is applica- adequate?
ble to other modes of chromatography that End
use a gradient system such as hydrophobic Yes
Remove resin
interaction and reversed-phase chromatogra- from further
phy. Furthermore, the product in my study Yes Evaluate ce and tw consideration
was eluted using a salt gradient, as is typical
for protein products. The same philosophy Step 3: Run a comparison gradient
can be used to design a procedure that
addresses pH-change-induced elution in
Calculate recovery Economic
ion-exchange chromatography.
and pool purity considerations
The first step involves batch experiments
with all resins to compare their binding
characteristics with the product. The buffer Any resins
No Final decision
selection is based upon past experience with remaining?
the molecule and literature precedents. If the
product binds too weakly with the resin
(indicated by product in the flowthrough) or Figure 3: Resin screening protocol.
620 LCGC VOLUME 19 NUMBER 6 JUNE 2001 www.chromatographyonline.com

velocity — constant. I then analyze peak nated purity, the pool purity describes the equilibration buffer. After equilibration, I
fractions using the appropriate analytical quality of the pool. After I have determined loaded a protein solution that contained
method to obtain the product and impurity the product recovery and pool purity for 1–2 times the intended protein loading for
profiles. These profiles provide useful infor- each resin, I can use these criteria along with the respective column in milligrams protein
mation about the selectivity of the station- economic considerations to make a more per milliliter resin). After 30 min, I washed
ary phase; that is, the ability of the resin to accurate choice of the optimal resin. the columns with 5 mL of equilibration
differentiate between the product and the buffer and collected the flowthrough
impurities. Based upon these data, I elimi- Case Study stream. The protein was eluted with 10 mL
nate from further consideration resins that Resin screening for an anion-exchange of elution buffer (1 M sodium chloride in
show little or no selectivity. chromatography column: This case study the equilibration buffer), and the protein
For resins that show acceptable selectivity, presents data obtained during the optimiza- was collected separately. I analyzed the
I use data from the test gradient to deter- tion of an anion-exchange chromatography flowthroughs and the eluents for protein by
mine the ionic strength corresponding to column used in the purification process of UV absorbance at 280 nm and for its purity
the elution of the product from the resin a microbial-fermentation-derived protein by anion-exchange high performance liquid
(ce ) and the peak width at 20% height from molecule. chromatography (HPLC). As Table I shows,
the baseline (tw in minutes). I chose to screen nine anion-exchange most resins showed satisfactory binding
In the third step, I pack columns with resins: Bio-Rad High Q and Bio-Rad characteristics with the product. Only resin
resins that are still under evaluation and per- DEAE (Bio-Rad Laboratories, Hercules, 1 showed anomalous behavior in that the
form separations using a comparison gradi- California); Pharmacia DEAE FF, Pharma- product was not retained under these con-
ent. In a comparison gradient, the product cia Q FF, and Pharmacia Q HP (Amersham ditions, so resin 1 was removed from further
peak is eluted in the center of an n column Pharmacia Biotech Inc., Piscataway, New consideration.
volume gradient with the product peak Jersey); Whatman Q, Whatman QA52, and Next, I packed columns with 10 mL of
eluted in approximately m column volumes, Whatman DE53 (Whatman Inc., Clifton, the remaining eight resins and performed
where m and n are variables chosen depend- New Jersey); and TosoHaas Q650M (Tosoh separations using an identical test gradient
ing upon the purpose of the column. Elu- Biosep, Montgomeryville, Pennsylvania). of 0–500 mM sodium chloride in 20 col-
tion profiles obtained under these gradients I performed all chromatography experi- umn volumes of equilibration buffer. The
would produce very similar elution profiles ments using an Åkta Explorer chromatog- peak fractions were analyzed by anion-
and thus provide a fair comparison of per- raphy system (Amersham Pharmacia exchange HPLC. Figure 4 illustrates the
formance of the various resins. The com- Biotech). I chose the buffer and other oper- performance of resins 3–5 using a test gra-
parison gradient is defined to start at one ating conditions based upon prior experi- dient of 0–500 mM sodium chloride in 20
concentration (c1) and go to another con- ence with the protein molecule: I used a column volumes. The y axis in Figures 4
centration (c2 ) in n column volumes in the pre-equilibration buffer of 1 M Tris (pH and 5 denotes the peak area obtained upon
following manner: 8.5), an equilibration buffer of 50 mM Tris analysis by anion-exchange HPLC. The
(pH 8.5), and protein loading at 10 mg/mL flow velocity and the fraction sizes are listed
c B  c A tw v resin. Because the objective of this article is in the figure captions. It is evident that run-
c2  ce  n [1] to present an efficient resin screening proto- ning identical gradients with different resins
2mD V
col — not to recommend a particular resin leads to widely varying elution profiles in
— I will refer to these resins as resins 1 to 9 terms of the peak width and peak position
and (not in the same order as listed above). I in the overall gradient. The poor selectivity
expected that the optimum resin would vary obtained with resins 3–5 led to their elimi-
c B  c A tw v with the separation problem. nation from further consideration.
c1  ce  n [2] I packed the columns with 1 mL of resin As listed in Table I, only resins 6–9
2mD V
and equilibrated them for 30 min with the showed satisfactory selectivity between the

such that if c1  0, then c1  0


Table I: Final comparison of resins considered
where ce and tw are obtained under the test
Recovery† Pool Purity† Final
gradient (cA to c B in D column volumes), V
Resins* Binding Selectivity (mAU/mL) (%) Decision
is the column volume in milliliters, and v is
the flow velocity in milliliters per minute. I Resin 1 Unacceptable — — — —
use two parameters — product recovery and Resin 2 Satisfactory Unacceptable — — —
pool purity — to evaluate resin perfor- Resin 3 Satisfactory Unacceptable — — —
Resin 4 Satisfactory Unacceptable — — —
mance. Product recovery is defined as the
Resin 5 Satisfactory Unacceptable — — —
sum of product peak areas in milliab-
Resin 6 Satisfactory Satisfactory Unacceptable — —
sorbance units of the pooled fractions per Resin 7 Satisfactory Satisfactory 75.4 96.5 Unacceptable
milliliter of injected sample. Pool purity is Resin 8 Satisfactory Satisfactory 25.3 100 Unacceptable
defined as the purity of the total pool Resin 9 Satisfactory Satisfactory 81.5 97.7 Satisfactory
formed by combining the fractions that
meet the pooling criteria. Although the * Resins 1 to 9 (not in order) include Bio-Rad DEAE, Bio-Rad High Q, TosoHaas Q650M, Whatman Q, What-
man QA52, Whatman DE53, Pharmacia DEAE FF, Pharmacia Q FF, and Pharmacia Q HP.
product recovery measures the quantity of † Based on measurements by anion-exchange HPLC (anion-exchange HPLC).
product that can be recovered with desig-
622 LCGC VOLUME 19 NUMBER 6 JUNE 2001 www.chromatographyonline.com

product and the impurity. Because resin 9 anion-exchange HPLC) per milliliter of Figure 5 reinforces the understanding
exhibited better resolution than resin 6 and injected sample. Pool purity was defined as that performing separations with designed
they had identical matrix and ligand chem- the purity of the total pool formed by mix- comparison gradients yields similar elution
istry, the former was chosen over the latter ing the fractions that meet the pooling cri- profiles with different resins and enables fair
for further consideration. teria. Table II shows the calculation of the comparison of resin performance. Figure 5
I calculated comparison gradients for comparison gradient for these three resins, also illustrates that resin 8 showed good
resins 7–9 according to the procedure and Figure 5 illustrates the protein and purity but poor recovery. Resins 7 and 9
described above. Product recovery was impurity profiles obtained after fraction showed comparable recovery and pool
defined as the sum of product peak areas in analysis by anion-exchange HPLC. The fig- purity. Because of better selectivity, I chose
milliabsorbance units in the pooled frac- ure shows the product recovery and pool resin 9 as the resin for this purification
tions (having greater than 90% purity by purity values for the experiment. process and for further optimization of
buffer pH, protein loading, feed flow rate,
elution flow rate, gradient slope, and col-
Table II: Calculation of the comparison gradients* umn length.

tw ce cA cB V v c1 c2 Summary
Resins† (min) (mM) (mM) (mM) D‡ (mL) (mL/min) (mM) (mM) Table I summarizes the results I obtained
Resin 7 5.21 110 100 200 20 10 1.7 90 130 using this resin screening strategy. I screened
Resin 8 6.61 109 100 200 20 10 0.9 80 130 a total of nine resins. Based upon my expe-
Resin 9 7.35 146 100 300 20 10 1.7 100 200 rience, this protocol presents a method for
efficient screening of resins and allows me to
* Symbols used in Table II are described in the text.
† Same as Table I.
screen 10 resins in a month. Because resins
‡ Number of column volumes. differ in their physicochemical interactions
with the various feed components, using
screening techniques allows analysts to opti-
mize the chromatographic process.

Acknowledgments
(a) (a) Pool purity: 96% The author would like to thank J.O.
Protein Polazzi, R.A. Heeren, G.V. Johnson, and
Injection (mAU/L)

Protein
Injection (mAU/L)

200 anion-exchange HPLC 70


anion-exchange HPLC B.K. Matthews of Pharmacia Corp. (Ches-
60
150 Impurity
50 Impurity
anion-exchange HPLC anion-exchange HPLC terfield, Missouri) for their help in experi-
100 40
30
mentation and M.E. Gustafson, D.E.
50
20 Steinmeyer, and J.K. McLaughlin, also of
0
10 Pharmacia, for their review of the manu-
0 script and helpful discussions.
(b) 350
(b)
300 References
Injection (mAU/L)

Injection (mAU/L)

Pool purity: 100% (1) J.-C. Janson and P. Hedman, Adv. Biochem.
250 40
Eng. 25, 43–99 (1982).
200 30
20 (2) S. Fulton and T. Londo, in Bioseparations and
150 Bioprocessing, G. Subramanian, Ed. (Wiley-
10
100 0 VCH, New York, 1998), pp. 41–64.
50 (3) G. Sofer and L. Hagel, Handbook of Process
0 Chromatography (Academic Press, New York,
(c) 80 Pool purity: 98% 1997), p. 54.
(4) P. Hedman, J.C. Janson, B. Arve, and J.G.
Injection (mAU/L)

(c) 70
60 Gustafsson, in Eighth International Biotechnol-
Injection (mAU/L)

50 ogy Symposium, G. Durand, L. Bobichon, and J.


150 40 Florent, Eds. (Société Mycologique de France,
100 30 Paris, 1988), pp. 623–643.
50 20 (5) R. Wisniewski, E. Boschetti, and A. Jungbauer,
0 10 in Biotechnology and Biopharmaceutical Manu-
0 facturing, Processing and Preservation, K.E. Avis
0 2 4 6 8 10 12
0 5 10 15 and V.L. Wu, Eds. (Interpharm Press, Engle-
Fraction number wood, Colorado, 1996), pp. 61–198.
Fraction number
(6) G. Sofer and C. Munson, Bio/Technology 5,
239–244 (1987).
Figure 4: Performance under test gradients. Figure 5: Performance under comparison (7) T.C. Ransohoff, M.K. Murphy, and H.L.
(a) Resin 3: 100 cm/h, 0–500 mM sodium chlo- gradients. (a) Resin 7: 50 cm/h, 90–130 mM Levine, BioPharm 3(3), 20–26 (1990).
ride in 20 column volumes, 3-mL fractions. (b) sodium chloride in 11 column volumes, 75- (8) A.P. Peskin and S.R. Rudge, App. Biochem.
Resin 4: 100 cm/h, 0–500 mM sodium chloride in mAU/mL recovery. (b) Resin 8: 50 cm/h, 80–130 Biotech. 34/35, 49–59 (1992).
20 column volumes, 5-mL fractions. (c) Resin 5: mM sodium chloride in 11 column volumes, 25- (9) P.R. Levison, C. Mumford, M. Streater, A.
50 cm/h, 0–500 mM sodium chloride in 20 col- mAU/mL recovery. (c) Resin 9: 50 cm/h, 100–200 Brandt-Nielsen, N.D. Pathirana, and S.E. Bad-
umn volumes, 2-mL fractions. mM sodium chloride in 11 column volumes, 82- ger, J. Chromatogr. A 760, 151–158 (1997). 
mAU/mL recovery.

View publication stats

You might also like